The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health…
Browsing: BioTech
On June 14, two of Legend Capital’s portfolio companies, Innovent Biologics, Inc. (Innovent) and PT Etana Biotechnologies Indonesia (Etana), jointly…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key…
Leads to 70% renewable energy use on a global level and marks significant progress towards achieving net zero carbon emissions…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that it…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the…
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert…
On June 1, 2022, TOT BIOPHARM (Stock code: 1875. HK) announced that the company entered into a Share Subscription Agreement…
An osteoporotic fracture occurs every three seconds worldwide. With more than 50 per cent of the world’s hip fractures expected…
9-month revenue up nearly 12-fold to RM22.03 million Profit supported by higher margin immunotherapy and cell therapies Malaysian Genomics Resource…
Q&M Dental Group (Singapore) Limited, a leading private dental healthcare group in Asia, reported net profit excluding other gains or…
Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased…
Novotech, the leading Asia-Pacific biotech specialist CRO, has acquired US CRO NCGS as part of its expansion program, and can…
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced…
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to support Yayasan Seri…
Legend Capital’s portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage…
Legend Capital’s portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for…
Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital’s co-founded company Innostellar Biotherapeutics, announced that the clinical trial application…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…